Coombs and Gell1) classified allergic phenomena into four types, of which three (types I, II and III) are immediate-type, and one (type IV) is delayed-type. The former reactions are caused by humoral antibodies, while the latter is caused by a cellular antibody.
We have already reported that the carboxamidemethylated L chain2) and the carboxamidemethylated H and L chains') show anti-ulcerogenic and anti-inflammatory activities, respectively.
In this paper, we describe the effect of carboxamidemethylated Fc (CM-Fc) on various allergic models. 
Results
Type I Allergy The effects of CM-Fc and Fc on homologous PCA in rats are summarized in Table I . CM-Fc significantly depressed the colored area at a dose of 20 mg/kg by 38.8%, while Fc showed no depression at the same dose.
The effect of CM-Fc on heterologous PCA in guinea pigs was also examined. CM-Fc at a dose of 20 mg/kg significantly depressed the colored area (27.4% inhibition; Table II ).
Type II Allergy
The effects of CM-Fc and Fc on complement-dependent hemolysis are shown in Fig. 1 . Fc inhibited hemolysis dose-dependently; the inhibition reached 40% at a dose of 100 tg/ml. On the other hand, CM-Fc did not inhibit hemolysis at all.
Type III Allergy
We examined the effects of CM-Fc and Fc using the immuno-complex inflammatory model for the active Arthus reaction. The maximum swelling of the hind pad was observed after 3 h. Fc at a dose of 20 mg/kg did not depress the pad swelling at the indicated times, although CM-Fe at doses of 10 and 20 mg/kg significantly depressed the swelling (Fig. 2) .
Type IV Allergy
As regards delayed-type hypersensitivity response to picryl chloride, CM-Fc significantly depressed the ear swelling at the dose of 20 mg/kg when the reagent was administered twice, (Table III) .
The effects of CM-Fc and Fc on delayed-type hypersensitivity to MBSA are shown in Table IV . CM-Fc had a significant inhibitory capability at a dose of 20 mg/kg, and Fc slightly depressed the swelling at the dose of 20 mg/kg when the reagents were administered twice.
Discussion
Recently, we reported that bovine serum IgG L chain,18) carboxamidemethylated Bence Jones protein 19) and human serum IgG L chain (Fr. I-L)21 show anti-ulcerogenic activity based on their inhibition of gastric juice secretion. Moreover, Fr. I-L and Fr. I-H also had antiinflammatory activity.3) In this investigation, we prepared an Fc subfragment without the variable region for the purpose of obtaining a more homogenous structure from human serum IgG, and we obtained CM-Fc with a molecular weight of about 25000 (data not shown).
Coombs and GeV classified allergic phenomena into four types. First, CM-Fc was examined for type I, an immediate allergy caused by an IgE antibody. Homologous PCA reaction, generally used as a type I allergic model, was depressed by CM-Fc, but not by Fc. Heterologous PCA was also depressed by CM-Fc.
Type II allergy is characterized by cell destruction resulting from a combination of the surface antigen of plasma membrane and its antibody, which depends on the complement.20) CM-Fc did not inhibit complement-dependent hemolysis at all (Fig. 1) , and also showed little inhibition of hypotonic hemolysis (data not shown). As Fc inhibited complement-dependent hemolysis, it was assumed that the complement-binding site was lost after carboxamidemethylation.
Opie21) showed that type III allergy was due to antibody and antigen reacting in the tissue. Culbertson') and later Cannon and Marshall") demonstrated that the severity of this Type IV allergy is the phenomenon caused by lymphokines, which are released on contact of the antigen and sensitized T cells.25) CM-Fc depressed the delayed-type hypersensitivities to both picryl chloride and MBSA. Therefore, we supposed that CM-Fc affected the cellular immune system.
Thus, CM-Fc is a potentially useful drug for three allergy types (I, III and IV) whereas Fc is not. This finding that anti-allergic activity was not acquired on carboxamidemethylation is consistent with our previous findings.2,3,3,18,19) The next step will be a more detailed examination of the mechanism of action of CM-Fc.
